The National Institute on Aging has awarded a $3.5 million grant to the Emory University Nell Hodgson Woodruff School of Nursing to study an online tool's capacity to increase mastery among caregivers of persons with dementia.
Faculty members from the Nell Hodgson Woodruff School of Nursing and the University of Pittsburgh School of Nursing are teaming together to study the informal caregiving networks of older adults with dementia, with the goal of developing an interactive digital tool to capture the full scope of caregiving beyond the experience of primary caregivers.
The Emory University Nell Hodgson Woodruff School of Nursing has received a $3.9 million grant from the National Institute of Neurological Disorders and Stroke to study the contribution of the oral microbiome to Alzheimer’s disease risk.
Two teams of Emory researchers have discovered proteins in human cerebrospinal fluid that can serve as early indicators that the patient may develop Alzheimer's disease in the future.
Cast your vote for biomedical engineer Reza Sameni’s project to develop an in-ear AI technology that can lead to earlier detection of brain diseases such as dementia and Alzheimer’s.
The Goizueta Institute @Emory Brain Health and Emory Healthcare are collaborating with digital health company Linus Health to implement innovative digital cognitive assessments for primary care patients.
One of 16 recipients nationwide of AARP, Robert Wood Johnson Foundation Health Equity Innovations Fund Awards
Emory researchers are on the cusp of seeing in real time how brain diseases like Alzheimer’s and autism spectrum disorder affect a patient’s brain function.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
The National Institutes of Health has awarded a 2022 New Innovator Award to biomedical engineer Felipe Garcia Quiroz for his innovative molecular approaches to monitoring clumps of proteins associated with neurodegenerative diseases.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
The National Institute on Aging has awarded Deqiang Qiu, PhD, and colleagues a five-year $3.8 million grant to investigate advanced brain imaging techniques for Alzheimer’s disease. They will investigate how problems in blood flow, known as cerebrovascular impairment, contribute to the early phases of Alzheimer’s.
Boosting levels of norepinephrine may be able to stall neurodegeneration in people with early signs of Alzheimer’s disease, a study conducted at Emory Brain Health Center suggests.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
Research is an integral part of Emory, from the sciences to the humanities. Here’s a sample of recent grant awards across campus along with newly published research findings.
An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases. The scientists compared the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) with a rarer disease called spinocerebellar ataxia type 36 (SCA 36).
Emory has advanced to the second round of STAT Madness, the bracket competition for biomedical research. Vote for Emory's 2020 entry, detecting Alzheimer's and mild cognitive impairment using eye tracking.
The National Institute on Aging has awarded a five-year, $3.66 million grant to Emory's Nell Hodgson Woodruff School of Nursing to establish an Edward R. Roybal Center for Translational Research in the Behavioral and Social Sciences focused on dementia caregiving.
Emory researchers are giving us double the reasons to pay attention to our cardiovascular health — showing in a recently published study in the Journal of Alzheimer's Disease that good heart health can equal good brain health.
The National Institute on Aging is awarding approximately $37 million over five years to a team of international researchers, led by Emory, to help accelerate the development of promising new therapies that will effectively treat or prevent Alzheimer's disease.
The study, published in Annals of Neurology, examines potential reasons why African Americans are more likely to develop AD than Caucasians.
Emory is partnering with Georgia Public Broadcasting on Your Fantastic Mind, a new weekly TV series that features compelling stories on brain-related health and wellness. The show premieres Monday, Jan. 28 at 8 p.m. on GPB's statewide television network.
A new paradigm-shifting program at the Emory Brain Health Center aims to tackle early declines in memory, a condition that affects up to 20 percent of Americans over age 65. The program will combine research, clinical care and patient and caregiver support.
"The Spirit Lives On: Art and the Mind," a new permanent exhibit at the Woodruff Health Sciences Center Library, features art and photography by people with dementia illnesses and their caregivers from the Emory community.
Emory is forming a new center for the study of brain inflammation, a critical mechanism in several chronic diseases of the nervous system and neurodegenerative diseases.
Emory has renamed its Alzheimer's Disease Research Center the Goizueta Alzheimer's Disease Research Center in recognition of The Goizueta Foundation's ongoing support toward developing treatment for the disease.
The Emory University Alzheimer's Disease Research Center and Gwinnett County Alumnae Chapter of Delta Sigma Theta Sorority, Inc. will cohost a community brain health forum titled, "A Healthy Mind, A Healthy Life" on Thursday, May 3, at 9 a.m.
Georgia Gov. Nathan Deal declared "DNA Day in Georgia," part of a national celebration marking the completion of sequencing the human genome 15 years ago. In honor of the anniversary, read about 15 genomic advances and clinical programs from Emory and Children's Healthcare of Atlanta.
Through an unexpected discovery, Emory scientists working in David Katz's lab gain a new understanding of the pathology behind Alzheimer's and Parkinson's diseases.
Emory is participating in STAT Madness, a "March Madness" style bracket competition featuring biomedical research instead of basketball teams. Please vote!
The Emory Integrated Memory Care Clinic (IMCC) is the first nurse-led clinic in the nation specializing in primary care for dementia patients and the first nurse-led medical home at Emory Healthcare.
To underscore the value of financial planning for families dealing with Alzheimer's disease, the Emory Brain Health Center teamed up with Bank of America and U.S. Trust to host a Health and Wealth Symposium in January 2018. The event was presented by the Emory Office of Corporate Relations, which connects leading Emory faculty members with companies seeking to create positive change in the world.
A cellular traffic jam appears to affect neurons in most forms of ALS (amyotrophic lateral sclerosis), researchers at Emory University School of Medicine and Mayo Clinic, Jacksonville have shown.
Mi-Kyung Song, director of the Center for Nursing Excellence in Palliative Care in Emory School of Nursing, has received a $3 million grant from the National Institute on Aging for an advanced care plan for Alzheimer's disease.
The National Academy of Medicine (NAM) has elected Allan I. Levey, MD, PhD, and Robert F. Breiman, MD, to its 2017 class of leading health scientists and international members.
Removal of a regulatory gene called LSD1 in adult mice induces changes in gene activity that look unexpectedly like Alzheimer's disease, scientists have discovered.
The U.S. Department of Health and Human Services (HHS) has appointed Emory neurologist Allan Levey, MD, PhD to serve on the Advisory Council on Alzheimer's Research, Care, and Services.
The Alzheimer's Foundation of America is awarding a $50,000 grant to Emory University's Alzheimer's Disease Research Center to support education and community outreach efforts among the Atlanta metro area's African-American community.
With new tools, Emory researchers can now see granulins within cells, and propose that granulins have important jobs in lysosomes necessary to maintain brain health. Granulin deficiency plays a role in several neurodegenerative diseases.
Alzheimer's disease and Parkinson's disease affect different regions of the brain and have distinct genetic and environmental risk factors. But at the biochemical level, these two diseases start to look similar. That's how Emory scientists landed on a potential drug target for Parkinson's.
The heritable protein particles known as prions aren't bugs in our cells' operating system, they're poorly documented features. A yeast protein called Lsb2, which can trigger prion formation by other proteins, actually forms a "metastable" prion itself in response to elevated temperatures, Emory/Georgia Tech scientists report.
In Alzheimer's research, one particular protein looms large: plaque-forming amyloid-beta. What about all the other proteins in the brain? Proteomics -- analyzing in an "unbiased" way how all the proteins in the brain accumulate or disappear -- could provide clues to alternative mechanisms and even treatment strategies, scientists think.
Emory researchers are embarking on a new study focused on identifying factors that will predict who is at risk of developing Alzheimer's disease (AD). The goal of the Emory Healthy Brain Study is earlier detection of AD and someday prevention.
Emory University's Nell Hodgson Woodruff School of Nursing, Department of Neurology, and the Department of Psychiatry launch the academic health system's first nurse-led medical home.
A new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) is beginning enrollment at Emory University and University of California, Irvine.
A recent study published in The Gerontologist says understanding the emotional reactions of individuals diagnosed with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) will provide health care professionals with important information needed to develop suitable treatments.
Emory researchers seeking to better understand aging and age-related diseases have launched the Emory Healthy Aging Study. It is the largest-ever clinical research study in Atlanta with a goal of enrolling 100,000 people over the next four years.
A team of Emory researchers was awarded a $5.2 million, five-year grant from the National Institute on Aging to examine the connections between blood pressure regulation and Alzheimer's disease.
Allan Levey, director of Emory's Alzheimer's Disease Research Center, answers questions about the disease and related disorders, including early detection and development of future treatments.
Alzheimer's disease often runs in families, but the risk that runs through the Chastain family, which has been working with Emory, is higher than researchers have encountered before.
The Emory Alzheimer's Disease Research Center will host a musical celebration this month to raise awareness of Alzheimer's disease (AD), its impact on families and the importance of ongoing research participation.
Emory University researchers have conducted the only known meta-analysis of Alzheimer's disease incidence by race and found that African-Americans are 64 percent more likely to develop AD than Caucasians, after adjusting for age, gender and education.
An Emory study published today in the journal Women's Health Issues finds women bear six times the cost of Alzheimer's disease care, per capita, that men do.
Neuroscientist Larry Walker described how he has borrowed a technique from prion research to study different `strains¿ of the amyloid-B protein, which accumulates in clumps in the brains of people with Alzheimers The Alzheimers field has not been paying enough attention to whats happening in the prion field,¿ says Walker, who is based at Emory University in Atlanta, Georgia.
The Emory Alzheimer's Disease Research Center was awarded a $50,000 grant from the Blue Cross Blue Shield of Georgia Foundation to provide education and training on brain health and offer memory screenings for older adults in metro Atlanta. The event will bring together top experts in cognitive health management and clinical research programs.
Emory University researcher Whitney Wharton says African-Americans are more likely to become afflicted with vascular risk factors like high blood pressure, high cholesterol and diabetes, all which contribute to Alzheimer's. She is leading a clinical trial that hopes to determine if a medication used to treat high blood pressure might reduce the risk of Alzheimer's in Blacks.
Researchers at Emory University will soon begin a clinical trial to determine if one class of drugs used to lower blood pressure may also reduce the risk of Alzheimer's disease in African-Americans.
Emory University's Alzheimer's Disease Research Center will receive a transformational donation to support advanced research into early detection of Alzheimer's disease. The Goizueta Foundation is committing $25 million toward research aimed at fundamentally changing the way Alzheimer's disease is detected and treated.
In the latest episode of Emory Looks at Hollywood, Education Core Director in Emory University's Alzheimer's Disease Research Center Ken Hepburn analyzes the authenticity of the movie "Still Alice."
The Emory Alzheimer's Disease Research Center (ADRC) has received a $50,000 grant from the Blue Cross Blue Shield of Georgia Foundation to provide education on brain health and offer memory screenings for people of color.
Emory's Alzheimer's Disease Research Center has been awarded a five-year, $7.2 million grant from the National Institute on Aging to discover proteins altered by Alzheimer's in an effort to identify new therapeutic targets.
Researchers at Emory University School of Medicine are recruiting participants for a study investigating the genetic risk for developing mild cognitive impairment (MCI) an early precursor of Alzheimer's disease.
The Pat Summitt Foundation has announced the formation of a medical advisory council of prominent Alzheimer's disease experts from around the country to advise the foundation on medical and research issues.
A team of researchers has found that patients with Alzheimer's disease have significantly higher levels of DDE, the long-lasting metabolite of the pesticide DDT, in their blood than healthy people.
Patients with Alzheimer's disease have significantly higher levels of DDE, the long-lasting metabolite of the pesticide DDT, in their blood than healthy people, a team of researchers from Rutgers, Emory and UTSW has found.
Emory researchers have identified a pharmaceutical strategy to shut down beta-amyloid production and possibly slow Alzheimer's disease progression.
Researchers at Emory School of Medicine have identified a previously unrecognized type of pathology in the brains of patients with Alzheimer's disease.
Emory patient Charlie Shaffer and his wife, Harriet, have responded to his diagnosis of mild cognitive impairment (MCI) as they handle most challenges: with candor, courage, and action.
The Emory University Alzheimer's Disease Research Center, Emory Center for Health in Aging and the Fulton-DeKalb Hospital Authority will host the Registry for Remembrance free community forum, "Navigating the Complex Role of the Caregiver - What to Keep in Mind" on Tuesday, April 30, 2013, beginning at 9:00 a.m. at the Carter Center, 453 Freedom Parkway, Atlanta, GA, 30307.
Researchers have shown they can predict impending cognitive decline using a sensitive behavioral task up to three years in advance of clinical evidence.